Last reviewed · How we verify

NCT07133035

Investigation of Respiratory Function in Bruxism

Active, enrolled Last updated 20 August 2025
What this trial tests

trial testing Pulmonary function test in Bruxism in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 October 2024
Primary endpoint
31 August 2025
31 August 2025

Quick facts

Lead sponsorAtılım University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment40
Start date15 October 2024
Primary completion31 August 2025
Estimated completion31 August 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Atılım University

Who can join

Adults 18 to 45, any sex, with Bruxism or Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to evaluate the respiratory functions, sleep quality and headache severity of individuals with bruxism and to compare them with the control group without bruxism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pulmonary function test

Trials testing the same drug.

Other recruiting trials for Bruxism

Currently open trials in the same condition.

Other Atılım University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07133035.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing